Paul Breillat: Targeting Inflammatory Cell Death Pathways in VEXAS Syndrome
Paul Breillat, Assistant Clinical Fellow in Internal Medicine and Clinical Immunology at Cochin Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Excited to share our new publication in Blood on VEXAS syndrome!
In this study, we uncover a pathogenic axis in VEXAS linking UBA1 loss of function and defective ubiquitination to:
- RIPK1-mediated inflammatory cell death
- Impaired antimicrobial signaling
- Defective resolution of inflammation
These findings provide evidence that targeting inflammatory cell death pathways represents a promising therapeutic strategy in VEXAS syndrome.
This work would not have been possible without our extraordinary collaborators David Beck, Samuel Magaziner, Stéphane Camus.
Warm thanks to the Foundation for Medical Research and Fonds IMMUNOV for their invaluable support.
Thanks also to the team at Paris Cardiovascular Research Center – PARCC and to INSERM for providing such a stimulating research environment.
Finally, special thanks to Benjamin Terrier for his mentorship and guidance throughout this project.”
Title: Inflammatory cell death and monocyte dysfunction in VEXAS syndrome
Authors: Paul Breillat, Samuel J Magaziner, Stéphane M. Camus, Léa Dionet, Benjamin De Valence De Minardiere, Pierre Sohier, Amine Majdi, Quentin Delcros, Federica Pallotti, Nadia Rivet, Kevin Chevalier, Margot Poux, Sr., Athena Lam, Pierre-Louis Tharaux, Olivia Lenoir, Abdelrahim Zoued, Olivier Kosmider, David B. Beck, Benjamin Terrier
Read the Full Article on Blood.

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 31, 2026, 19:25Jessica Garcia: Real-World Evidence on Efanesoctocog Alfa Prophylaxis in Pediatric Hemophilia A
-
Oct 31, 2026, 19:21Cedric Hermans: What If Higher Plasma FIX Levels Do Not Necessarily Mean better Haemostatic Protection?
-
Oct 31, 2026, 19:16Valance Washington: Celebrating Sravya Nimmala’s Outstanding Abstract Award
-
Oct 31, 2026, 16:41Ward Faisal: Ferric Carboxymaltose as an Alternative to Traditional Iron Preparations for Anemia
-
Oct 31, 2026, 16:35Bhavna Daryani: Using Technology to Make Anemia Screening More Accessible and Non-Invasive
-
Oct 31, 2026, 16:33Greg Jackson: Key Insights from the 22nd Annual McMaster Hematology and Thromboembolism Update
-
Oct 31, 2026, 16:29Joseph R. Shaw: Pharmacology Behind Anticoagulant Bleeding Risk
-
Oct 31, 2026, 16:23Julia Schneider: Advancing Stroke Care Together on World Stroke Day
-
Oct 31, 2026, 16:19Gaurav Dixit: Understanding Bone Marrow and Its Essential Role in Hematopoiesis